Fortress Biotech, Inc.

Healthcare · Biotechnology · United States

Last price 2 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 66.70M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne; Amzeeq, a minocycline topical foam for the treatment of lesions of non-nodular moderate to severe acne vulgaris; Zilxi, a minocycl...